World's Best Scientists 2026 revealed!
Russell D. Hull

Russell D. Hull

D-Index & Metrics

Medicine

D-Index
77
Citations
30463
World Ranking
18274
National Ranking
769

Overview

Russell D. Hull is affiliated with the University of Calgary in Canada and has contributed to the field of Medicine through research focused primarily on venous thromboembolism and cardiovascular conditions. Their work spans multiple subfields including Internal Medicine, Cardiology and Cardiovascular Medicine, Epidemiology, and Health, Toxicology and Mutagenesis.

Their research topics include:

  • Venous Thromboembolism Diagnosis and Management
  • Acute Myocardial Infarction Research
  • Atrial Fibrillation Management and Outcomes
  • Acute Ischemic Stroke Management
  • Blood Pressure and Hypertension Studies
  • Sepsis Diagnosis and Treatment
  • Climate Change and Health Impacts

Notable recent papers by Russell D. Hull include:

  • Machine learning to predict venous thrombosis in acutely ill medical patients, 2020, Research and Practice in Thrombosis and Haemostasis
  • External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial, 2022, Journal of Thrombosis and Thrombolysis
  • Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial, 2022, Thrombosis Research
  • Masthead, 2022, The American Journal of Medicine

Frequent coauthors in their research include:

  • Gerald Chi
  • Adrian F. Hernandez
  • Robert A. Harrington
  • Samuel Z. Goldhaber
  • C. Michael Gibson

Russell D. Hull's publications appear in several prominent journals, including:

  • Research and Practice in Thrombosis and Haemostasis
  • Journal of Thrombosis and Thrombolysis
  • Thrombosis Research
  • The American Journal of Medicine

Best Publications

  • Antithrombotic therapy for venous thromboembolic disease.

    Thomas M. Hyers;Russell D. Hull;John G. Weg

  • Multidetector Computed Tomography for Acute Pulmonary Embolism

    Paul D. Stein;Sarah E. Fowler;Lawrence R. Goodman;Alexander Gottschalk

  • Antithrombotic Therapy for Venous Thromboembolic Disease : The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

    Harry R. Büller;Giancarlo Agnelli;Russel D. Hull;Thomas M. Hyers

  • A Randomized, Controlled Trial of the Use of Pulmonary-Artery Catheters in High-Risk Surgical Patients

    James Dean Sandham;Russell Douglas Hull;Rollin Frederick Brant;Linda Knox

  • D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review.

    Stein Pd;Hull Rd;Patel Kc;Olson Re

  • Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.

    Hull Rd;Raskob Ge;Pineo Gf;Green D

  • Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

    R D Hull;G E Raskob;J Hirsh;R M Jay

  • Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

    R. Hull;J. Hirsh;R. Jay;C. Carter

  • Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.

    Russell Hull;Terry Delmore;Edward Genton;Jack Hirsh

  • Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis

    Russell D. Hull;Gary E. Raskob;David Rosenbloom;Akbar A. Panju

  • Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

    Alexander T. Cohen;Theodore E. Spiro;Harry R. Büller;Lloyd Haskell

  • A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.

    Alexander G.G. Turpie;Mark N. Levine;Jack Hirsh;Cedric J. Carter

  • Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer

    Russell D. Hull;Graham F. Pineo;Rollin F. Brant;Andrew F. Mah

  • Diagnostic pathways in acute pulmonary embolism: Recommendations of the PIOPED II - Investigators

    Paul D. Stein;Pamela K. Woodard;John G. Weg;Thomas W. Wakefield

  • A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.

    R Hull;G Raskob;G Pineo;D Rosenbloom

  • Clinical Characteristics of Patients with Acute Pulmonary Embolism: Data from PIOPED II

    Paul D. Stein;Afzal Beemath;Fadi Matta;John G. Weg

  • Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.

    Russell Hull;Terry Delmore;Cedric Carter;Jack Hirsh

  • Diagnostic Value of Ventilation-Perfusion Lung Scanning in Patients with Suspected Pulmonary Embolism

    Russell D. Hull;Jack Hirsh;Cedric J. Carter;Gary E. Raskob

  • Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility: A Randomized Trial

    Russell D Hull;Sebastian M Schellong;Victor F Tapson;Manuel Monreal

  • Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

    Alexander T. Cohen;Robert A. Harrington;Samuel Z. Goldhaber;Russell D. Hull

Frequent Co-Authors

Gary E. Raskob
Gary E. Raskob University of Oklahoma Health Sciences Center
Paul D. Stein
Paul D. Stein Michigan State University
Samuel Z. Goldhaber
Samuel Z. Goldhaber Brigham and Women's Hospital
Adrian F. Hernandez
Adrian F. Hernandez Duke University
Jack Hirsh
Jack Hirsh McMaster University
Robert A. Harrington
Robert A. Harrington Cornell University
Rollin Brant
Rollin Brant University of British Columbia
Alexander G.G. Turpie
Alexander G.G. Turpie McMaster University
C. Michael Gibson
C. Michael Gibson Beth Israel Deaconess Medical Center
Victor F. Tapson
Victor F. Tapson Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative routes, several allied health and management fields offer versatile and rewarding careers. Aspiring nurses can explore a nursing school that does not require teas test, making it easier to begin their journey into nursing without the added pressure of entrance exams.

Leadership opportunities in healthcare are growing rapidly. Earning a healthcare administration degree online accredited can help you step into management roles within hospitals, clinics, or health organizations—all with the flexibility of online learning.

Registered nurses looking to advance their clinical skills can consider rn to np programs, which streamline the pathway from ADN to MSN and open doors to becoming a nurse practitioner.

For those passionate about nutrition and preventative care, pursuing an online nutritionist degree is an excellent way to contribute to public health. Each of these online options can provide a flexible, respected alternative for building a healthcare career in the USA.

Best Scientists Citing Russell D. Hull

Trending Scientists

Recently Published Articles